{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:38:50Z","timestamp":1791463130699,"version":"4.3.4"},"reference-count":110,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T00:00:00Z","timestamp":1643587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["209589\/Z\/17\/Z"],"award-info":[{"award-number":["209589\/Z\/17\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G1002033"],"award-info":[{"award-number":["G1002033"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N022556\/1"],"award-info":[{"award-number":["MR\/N022556\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000723","name":"Tenovus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000723","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Reprod. Health"],"abstract":"<jats:p>Abnormal uterine bleeding (AUB) is experienced by up to a third of women of reproductive age. It can cause anaemia and often results in decreased quality of life. A range of medical and surgical treatments are available but are associated with side effects and variable effectiveness. To improve the lives of those suffering from menstrual disorders, delineation of endometrial physiology is required. This allows an increased understanding of how this physiology may be disturbed, leading to uterine pathologies. In this way, more specific preventative and therapeutic strategies may be developed to personalise management of this common symptom. In this review, the impact of AUB globally is outlined, alongside the urgent clinical need for improved medical treatments. Current knowledge of endometrial physiology at menstruation is discussed, focusing on endocrine regulation of menstruation and local endometrial inflammation, tissue breakdown, hypoxia and endometrial repair. The contribution of the specialised endometrial vasculature and coagulation system during menstruation is highlighted. What is known regarding aberrations in endometrial physiology that result in AUB is discussed, with a focus on endometrial disorders (AUB-E) and adenomyosis (AUB-A). Gaps in existing knowledge and areas for future research are signposted throughout, with a focus on potential translational benefits for those experiencing abnormal uterine bleeding. Personalisation of treatment strategies for menstrual disorders is then examined, considering genetic, environmental and demographic characteristics of individuals to optimise their clinical management. Finally, an ideal model of future management of AUB is proposed. This would involve targeted diagnosis of specific endometrial aberrations in individuals, in the context of holistic medicine and with due consideration of personal circumstances and preferences.<\/jats:p>","DOI":"10.3389\/frph.2021.794352","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T05:02:51Z","timestamp":1643605371000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["The Menstrual Endometrium: From Physiology to Future Treatments"],"prefix":"10.3389","volume":"3","author":[{"given":"Marianne","family":"Watters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Mart\u00ednez-Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline A.","family":"Maybin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ijgo.2010.11.011","article-title":"FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age","volume":"113","author":"Munro","year":"2011","journal-title":"Int J Gynaecol Obstet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/ijgo.12666","article-title":"The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions","volume":"143","author":"Munro","year":"2018","journal-title":"Int J Gynaecol Obstet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/S0849-5831(16)31463-X","article-title":"Guidelines for the management of abnormal uterine bleeding: these guidelines have been reviewed by the clinical practice gynaecology and the reproductive endocrinology infertility committees, and approved by executive and council of the society of obstetricians and gynaecologists of Canada","volume":"23","author":"Vilos","year":"2001","journal-title":"J SOGC."},{"key":"B4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1524-4733.2007.00168.x","article-title":"A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in abnormal uterine bleeding","volume":"10","author":"Liu","year":"2007","journal-title":"Value Health."},{"key":"B5","author":"MORI","year":"2012","journal-title":"National Heavy Menstrual Bleeding Audit: Second Annual Report"},{"key":"B6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.bpobgyn.2015.11.012","article-title":"Abnormal uterine bleeding","volume":"34","author":"Whitaker","year":"2016","journal-title":"Best Pract Res Clin Obstet Gynaecol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/1471-0528.14385","article-title":"Premenopausal abnormal uterine bleeding and risk of endometrial cancer","volume":"124","author":"Pennant","year":"2017","journal-title":"BJOG."},{"key":"B8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s11154-012-9226-4","article-title":"Endometrial haemostasis and menstruation","volume":"13","author":"Davies","year":"2012","journal-title":"Rev Endocr Metab Disord."},{"key":"B9","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/0002-9378(79)90302-8","article-title":"Proliferation kinetics of human endometrium during the normal menstrual cycle","volume":"133","author":"Ferenczy","year":"1979","journal-title":"Am J Obstet Gynecol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1469-185X.1986.tb00657.x","article-title":"Implantation, menstruation and inflammation","volume":"61","author":"Finn","year":"1986","journal-title":"Biol Rev."},{"key":"B11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/molehr\/7.2.175","article-title":"The NF-\u03baB pathway in human endometrium and first trimester decidua","volume":"7","author":"King","year":"2001","journal-title":"Mol Hum Reprod."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1530\/rep.0.1210003","article-title":"Cytokine control in human endometrium","volume":"121","author":"Kelly","year":"2001","journal-title":"Reproduction."},{"key":"B13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1095\/biolreprod.113.108175","article-title":"Decidualized human endometrial stromal cells are sensors of hormone withdrawal in the menstrual inflammatory cascade","volume":"90","author":"Evans","year":"2014","journal-title":"Biol Reprod."},{"key":"B14","doi-asserted-by":"publisher","first-page":"17416","DOI":"10.1038\/s41598-017-17565-x","article-title":"Endometrial apoptosis and neutrophil infiltration during menstruation exhibits spatial and temporal dynamics that are recapitulated in a mouse model","volume":"7","author":"Armstrong","year":"2017","journal-title":"Sci Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11154-012-9223-7","article-title":"Inflammation, leukocytes and menstruation","volume":"13","author":"Evans","year":"2012","journal-title":"Rev Endocr Metab Disord."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/humrep\/deaa065","article-title":"Endometrial inflammasome activation accompanies menstruation and may have implications for systemic inflammatory events of the menstrual cycle","volume":"35","author":"Azlan","year":"2020","journal-title":"Hum Reprod."},{"key":"B17","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: mechanism of action, role in disease, and therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-0378(99)00002-9","article-title":"Menstruation: induction by matrix metalloproteinases and inflammatory cells","volume":"44","author":"Salamonsen","year":"1999","journal-title":"J Reproduct Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1210\/en.2014-1029","article-title":"ROS are critical for endometrial breakdown via NF-\u03baB\u2013COX-2 signaling in a female mouse menstrual-Like Model","volume":"155","author":"Wu","year":"2014","journal-title":"Endocrinology."},{"key":"B20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1677\/joe.1.05754","article-title":"Steroid signalling in human ovarian surface epithelial cells: the response to interleukin-1alpha determined by microarray analysis","volume":"183","author":"Rae","year":"2004","journal-title":"J Endocrinol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.mce.2005.12.010","article-title":"11Beta-hydroxysteroid dehydrogenases in human endometrium","volume":"248","author":"McDonald","year":"2006","journal-title":"Mol Cell Endocrinol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1210\/jc.2016-3437","article-title":"Reduced transforming growth factor-\u03b2 activity in the endometrium of women with heavy menstrual bleeding","volume":"102","author":"Maybin","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"key":"B23","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.coph.2009.04.008","article-title":"Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity","volume":"9","author":"Sanjabi","year":"2009","journal-title":"Curr Opin Pharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1189\/jlb.5A0215-061RR","article-title":"Cortisol regulates the paracrine action of macrophages by inducing vasoactive gene expression in endometrial cells","volume":"99","author":"Thiruchelvam","year":"2016","journal-title":"J Leukoc Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1210\/jc.2016-3604","article-title":"Steroids regulate CXCL4 in the human endometrium during menstruation to enable efficient endometrial repair","volume":"102","author":"Maybin","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"key":"B26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nri2294","article-title":"Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators","volume":"8","author":"Serhan","year":"2008","journal-title":"Nat Rev Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1530\/REP-11-0021","article-title":"role for lipoxin A4 as an anti-inflammatory mediator in the human endometrium","volume":"142","author":"Macdonald","year":"2011","journal-title":"Reproduction."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1093\/humrep\/12.6.1300","article-title":"Chemokine and cyclooxygenase-2 expression in human endometrium coincides with leukocyte accumulation","volume":"12","author":"Jones","year":"1997","journal-title":"Hum Reprod."},{"key":"B29","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1046\/j.1365-2265.2001.01432.x","article-title":"The endocrinology of menstruation - a role for the immune system","volume":"55","author":"Critchley","year":"2001","journal-title":"Clin Endocrinol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1262\/jrd.50.215","article-title":"Withdrawal of ovarian steroids stimulates prostaglandin F2alpha production through nuclear factor-kappaB activation via oxygen radicals in human endometrial stromal cells: potential relevance to menstruation","volume":"50","author":"Sugino","year":"2004","journal-title":"J Reprod Dev."},{"key":"B31","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1046\/j.1440-1681.1999.03012.x","article-title":"Endometrial endothelin: regulator of uterine bleeding and endometrial repair","volume":"26","author":"Salamonsen","year":"1999","journal-title":"Clin Exp Pharmacol Physiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"515","DOI":"10.4103\/0019-5049.144643","article-title":"Overview of the coagulation system","volume":"58","author":"Palta","year":"2014","journal-title":"Indian J Anaesth."},{"key":"B33","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1111\/j.1476-5381.1995.tb13300.x","article-title":"Haemostatic mechanism in the endometrium: role of cyclo-oxygenase products and coagulation factors","volume":"114","author":"Gelety","year":"1995","journal-title":"Br J Pharmacol."},{"key":"B34","first-page":"219","article-title":"Menstruation in intraocular endometrial transplants in the rhesus monkey","author":"Markee","year":"1940","journal-title":"Contrib Embryol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1096\/fj.08-111401","article-title":"VEGF blockade inhibits angiogenesis and reepithelialization of endometrium","volume":"22","author":"Fan","year":"2008","journal-title":"FASEB J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13104-016-1842-8","article-title":"Hypoxyprobe\u2122 reveals dynamic spatial and temporal changes in hypoxia in a mouse model of endometrial breakdown and repair","volume":"9","author":"Cousins","year":"2016","journal-title":"BMC Res Notes."},{"key":"B37","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41467-017-02375-6","article-title":"Hypoxia and hypoxia inducible factor-1\u03b1 are required for normal endometrial repair during menstruation","volume":"9","author":"Maybin","year":"2018","journal-title":"Nat Commun."},{"key":"B38","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1093\/humrep\/deaa379","article-title":"Markers of human endometrial hypoxia can be detected in vivo and ex vivo during physiological menstruation","volume":"36","author":"Reavey","year":"2021","journal-title":"Human Reproduction."},{"key":"B39","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1210\/en.2005-1153","article-title":"Hypoxia-inducible factor-1alpha expression in human endometrium and its regulation by prostaglandin E-series prostanoid receptor 2 (EP2)","volume":"147","author":"Critchley","year":"2006","journal-title":"Endocrinology."},{"key":"B40","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.1096\/fj.13-232074","article-title":"Hypoxia is not required for human endometrial breakdown or repair in a xenograft model of menstruation","volume":"27","author":"Coudyzer","year":"2013","journal-title":"FASEB J."},{"key":"B41","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"Semenza Gregg","year":"2012","journal-title":"Cell."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1093\/humrep\/der476","article-title":"The presence and regulation of connective tissue growth factor in the human endometrium","volume":"27","author":"Maybin","year":"2012","journal-title":"Hum Reprod."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1210\/en.2010-1256","article-title":"The expression and regulation of Adrenomedullin in the human endometrium: a candidate for endometrial repair","volume":"152","author":"Maybin","year":"2011","journal-title":"Endocrinology."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.ajpath.2010.11.070","article-title":"Novel roles for hypoxia and prostaglandin E2 in the regulation of IL-8 during endometrial repair","volume":"178","author":"Maybin","year":"2011","journal-title":"Am J Pathol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.bpobgyn.2006.01.006","article-title":"The symptomatology of adenomyosis","volume":"20","author":"Peric","year":"2006","journal-title":"Best Pract Res Clin Obstet Gynaecol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jmig.2017.08.653","article-title":"Transvaginal ultrasound for the diagnosis of Adenomyosis: systematic review and meta-analysis","volume":"25","author":"Andres","year":"2018","journal-title":"J Minim Invasive Gynecol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/humupd\/8.1.60","article-title":"Mechanisms of abnormal uterine bleeding","volume":"8","author":"Livingstone","year":"2002","journal-title":"Hum Reprod Update."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1093\/humrep\/del089","article-title":"Reduced levels of VEGF-A and MMP-2 and MMP-9 activity and increased TNF-\u03b1 in menstrual endometrium and effluent in women with menorrhagia","volume":"21","author":"Malik","year":"2006","journal-title":"Hum Reprod."},{"key":"B49","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.smim.2014.05.004","article-title":"Regulation of NF-\u03baB by TNF family cytokines","volume":"26","author":"Hayden","year":"2014","journal-title":"Semin Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/humrep\/del503","article-title":"Cyclooxygenase enzyme expression and E series prostaglandin receptor signalling are enhanced in heavy menstruation","volume":"22","author":"Smith","year":"2007","journal-title":"Hum Reprod."},{"key":"B51","doi-asserted-by":"publisher","first-page":"123","DOI":"10.5468\/ogs.2016.59.2.123","article-title":"Increased expression of nuclear factor kappa-B p65 subunit in adenomyosis","volume":"59","author":"Park","year":"2016","journal-title":"Obstet Gynecol Sci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.fertnstert.2013.04.028","article-title":"Constitutive and tumor necrosis factor-\u03b1-induced activation of nuclear factor-\u03baB in adenomyosis and its inhibition by andrographolide","volume":"100","author":"Li","year":"2013","journal-title":"Fertil Steril."},{"key":"B53","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1034\/j.1600-0897.2002.01040.x","article-title":"Cytokine network of eutopic and ectopic endometrium in women with adenomyosis","volume":"47","author":"Sotnikova","year":"2002","journal-title":"Am J Reprod Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.fertnstert.2009.01.084","article-title":"Immunoreactivity of progesterone receptor isoform B, nuclear factor kappaB, and IkappaBalpha in adenomyosis","volume":"92","author":"Nie","year":"2009","journal-title":"Fertil Steril."},{"key":"B55","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3892\/mmr.2018.9618","article-title":"Correlation of LOX-5 and COX-2 expression with inflammatory pathology and clinical features of adenomyosis","volume":"19","author":"Li","year":"2019","journal-title":"Mol Med Rep."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1210\/jc.2008-1879","article-title":"Cortisol Inactivation by 11\u03b2-Hydroxysteroid dehydrogenase-2 may enhance endometrial angiogenesis via reduced thrombospondin-1 in heavy menstruation","volume":"94","author":"Rae","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1093\/humrep\/12.9.2036","article-title":"Endothelin and neutral endopeptidase in the endometrium of women with menorrhagia","volume":"12","author":"Marsh","year":"1997","journal-title":"Hum Reprod."},{"key":"B58","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1471-0528.1981.tb01009.x","article-title":"Prostaglandin synthesis in the endometrium of women with ovular disfunctional uterine bleeding","volume":"88","author":"Smith","year":"1981","journal-title":"BJOG Int J Obstet Gynaecol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.fertnstert.2010.01.070","article-title":"Suppression of migratory\/invasive ability and induction of apoptosis in adenomyosis-derived mesenchymal stem cells by cyclooxygenase-2 inhibitors","volume":"94","author":"Chen","year":"2010","journal-title":"Fertil Steril."},{"key":"B60","doi-asserted-by":"publisher","first-page":"gaab029","DOI":"10.1093\/molehr\/gaab029","article-title":"In the mouse, prostaglandin D2 signalling protects the endometrium against adenomyosis","volume":"27","author":"Philibert","year":"2021","journal-title":"Mol Hum Reprod."},{"key":"B61","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/j.1471-0528.1993.tb14272.x","article-title":"Endometrial fibrinolytic enzymes in women with normal menstruation and dysfunctional uterine bleeding","volume":"100","author":"Gleeson","year":"1993","journal-title":"Br J Obstet Gynaecol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1007\/s43032-021-00513-6","article-title":"Immunoreactivity of Plasminogen activator inhibitor 1 and its correlation with dysmenorrhea and lesional fibrosis in adenomyosis","volume":"28","author":"Yang","year":"2021","journal-title":"Reprod sci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/humrep\/deq311","article-title":"Elevated immunoreactivity to tissue factor and its association with dysmenorrhea severity and the amount of menses in adenomyosis","volume":"26","author":"Liu","year":"2010","journal-title":"Hum Reprod."},{"key":"B64","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.rbmo.2020.07.023","article-title":"Adenomyosis in mice resulting from mechanically or thermally induced endometrial\u2013myometrial interface disruption and its possible prevention","volume":"41","author":"Hao","year":"2020","journal-title":"Reprod Biomed Online."},{"key":"B65","doi-asserted-by":"publisher","first-page":"640065","DOI":"10.3389\/fcell.2021.640065","article-title":"Transforming growth factor (TGF) \u03b2 and endometrial vascular maturation","volume":"9","author":"Lu","year":"2021","journal-title":"Front Cell Dev Biol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.fertnstert.2006.11.190","article-title":"Wall discontinuities and increased expression of vascular endothelial growth factor-A and vascular endothelial growth factor receptors 1 and 2 in endometrial blood vessels of women with menorrhagia","volume":"88","author":"Mints","year":"2007","journal-title":"Fertil Steril."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/humrep\/14.4.1072","article-title":"Vascular smooth muscle cell proliferation in arterioles of the human endometrium","volume":"14","author":"Abberton","year":"1999","journal-title":"Hum Reprod."},{"key":"B68","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1093\/humrep\/14.12.3095","article-title":"Smooth muscle alpha actin and myosin heavy chain expression in the vascular smooth muscle cells surrounding human endometrial arterioles","volume":"14","author":"Abberton","year":"1999","journal-title":"Hum Reprod."},{"key":"B69","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/humrep\/dex378","article-title":"Endometrial vascular development in heavy menstrual bleeding: altered spatio-temporal expression of endothelial cell markers and extracellular matrix components","volume":"33","author":"Biswas Shivhare","year":"2018","journal-title":"Hum Reprod."},{"key":"B70","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1093\/humrep\/dew018","article-title":"Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis\u2020","volume":"31","author":"Liu","year":"2016","journal-title":"Hum Reprod."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.fertnstert.2015.12.019","article-title":"Expression of GRIM-19 in adenomyosis and its possible role in pathogenesis","volume":"105","author":"Wang","year":"2016","journal-title":"Fertil Steril."},{"key":"B72","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000094426","article-title":"Matrix metalloproteinase-2 and\u22129 expression correlated with angiogenesis in human adenomyosis","volume":"62","author":"Li","year":"2006","journal-title":"Gynecol Obstet Invest."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1111\/jcmm.12300","article-title":"Oestrogen-induced angiogenesis promotes adenomyosis by activating the Slug-VEGF axis in endometrial epithelial cells","volume":"18","author":"Huang","year":"2014","journal-title":"J Cell Mol Med."},{"key":"B74","article-title":"National Institute for Health and Care Excellence (NICE)","year":"2018","journal-title":"Heavy Menstrual Bleeding: Assessment And Management"},{"key":"B75","doi-asserted-by":"publisher","first-page":"CD000154","DOI":"10.1002\/14651858.CD000154.pub3","article-title":"Combined hormonal contraceptives for heavy menstrual bleeding","volume":"2","author":"Lethaby","year":"2019","journal-title":"Cochrane Database Syst Rev."},{"key":"B76","year":"2016","journal-title":"The Faculty of Sexual & Reproductive Healthcare of the Royal College of Obstetricians & Gynaecologists (FSRH)"},{"key":"B77","doi-asserted-by":"publisher","first-page":"d2202","DOI":"10.1136\/bmj.d2202","article-title":"Hysterectomy, endometrial ablation, and levonorgestrel releasing intrauterine system (Mirena) for treatment of heavy menstrual bleeding: cost effectiveness analysis","volume":"342","author":"Roberts","year":"2011","journal-title":"BMJ."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta15190","article-title":"Hysterectomy, endometrial ablation and Mirena\u00ae for heavy menstrual bleeding: a systematic review of clinical effectiveness and cost-effectiveness analysis","volume":"15","author":"Bhattacharya","year":"2011","journal-title":"Health Technol Assess."},{"key":"B79","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.contraception.2015.05.015","article-title":"Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial","volume":"92","author":"Shaaban","year":"2015","journal-title":"Contraception."},{"key":"B80","year":"2015","journal-title":"Intrauterine Contraception."},{"key":"B81","doi-asserted-by":"publisher","first-page":"Cd000547","DOI":"10.1002\/14651858.CD000547","article-title":"Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids","volume":"2","author":"Lethaby","year":"2001","journal-title":"Cochrane Database Syst Rev."},{"key":"B82","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1447-0756.2000.tb01334.x","article-title":"A prospective randomized study comparing endocrinological and clinical effects of two types of GnRH agonists in cases of uterine leiomyomas or endometriosis","volume":"26","author":"Takeuchi","year":"2000","journal-title":"J Obstet Gynaecol Res."},{"key":"B83","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ijgo.2008.10.032","article-title":"Gonadotropin-releasing hormone analog combined with a low-dose oral contraceptive to treat heavy menstrual bleeding","volume":"104","author":"Cetin","year":"2009","journal-title":"Int J Gynaecol Obstet."},{"key":"B84","doi-asserted-by":"publisher","first-page":"Cd000400","DOI":"10.1002\/14651858.CD000400.pub3","article-title":"Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding","volume":"1","author":"Lethaby","year":"2013","journal-title":"Cochrane Database Syst Rev."},{"key":"B85","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/00006254-198205000-00015","article-title":"Efficacy of mefenamic acid in patients with a complaint of menorrhagia","volume":"58","author":"Fraser","year":"1981","journal-title":"Obstet Gynecol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/j.1471-0528.1987.tb03150.x","article-title":"Control of menorrhagia by the cyclo-oxygenase inhibitors naproxen sodium and mefenamic acid","volume":"94","author":"Hall","year":"1987","journal-title":"Br J Obstet Gynaecol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1111\/j.1471-0528.1986.tb08019.x","article-title":"Primary and myoma-associated menorrhagia: role of prostaglandins and effects of ibuprofen","volume":"93","author":"M\u00e4k\u00e4r\u00e4inen","year":"1986","journal-title":"Br J Obstet Gynaecol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1097\/AOG.0b013e3182839e0e","article-title":"Nonsurgical management of heavy menstrual bleeding: a systematic review","volume":"121","author":"Matteson","year":"2013","journal-title":"Obstet Gynecol."},{"key":"B89","author":"MORI","year":"2013","journal-title":"National Heavy Menstrual Bleeding Audit: Third Annual Report"},{"key":"B90","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1177\/1745505717692591","article-title":"Esmya(\u00ae) and the PEARL studies: a review","volume":"12","author":"Powell","year":"2016","journal-title":"Womens Health."},{"key":"B91","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/jog.13917","article-title":"Adverse symptoms during short-term use of ulipristal acetate in women with uterine myomas and\/or adenomyosis","volume":"45","author":"Hong","year":"2019","journal-title":"J Obstet Gynaecol Res."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.jmig.2018.04.002","article-title":"Ulipristal Acetate improves clinical symptoms in women with Adenomyosis and uterine myomas","volume":"25","author":"Gracia","year":"2018","journal-title":"J Minim Invasive Gynecol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.fertnstert.2021.02.008","article-title":"The endometrial response to modulation of ligand-progesterone receptor pathways is reversible","volume":"116","author":"Chodankar","year":"2021","journal-title":"Fertil Steril."},{"key":"B94","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1095\/biolreprod57.3.514","article-title":"Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium","volume":"57","author":"Kitawaki","year":"1997","journal-title":"Biol Reprod."},{"key":"B95","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1600-0412.2012.01350.x","article-title":"Aromatase inhibitors or gonadotropin-releasing hormone agonists for the management of uterine adenomyosis: a randomized controlled trial","volume":"91","author":"Badawy","year":"2012","journal-title":"Acta Obstet Gynecol Scand."},{"key":"B96","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.xfre.2021.05.004","article-title":"Efficacy and safety of elagolix with add-back therapy in women with uterine fibroids and coexisting adenomyosis","volume":"2","author":"Muneyyirci-Delale","year":"2021","journal-title":"F S Rep."},{"key":"B97","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.4049\/jimmunol.173.6.4207","article-title":"Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modification of reduced cysteine 62 of p50","volume":"173","author":"Xia","year":"2004","journal-title":"J Immunol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1177\/1933719111404610","article-title":"The retardation of myometrial infiltration, reduction of uterine contractility, and alleviation of generalized hyperalgesia in mice with induced adenomyosis by levo-tetrahydropalmatine (l-THP) and andrographolide","volume":"18","author":"Mao","year":"2011","journal-title":"Reprod Sci."},{"key":"B99","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3389\/fphar.2017.00460","article-title":"Drugs for autoimmune inflammatory diseases: from small molecule compounds to anti-TNF biologics","volume":"8","author":"Li","year":"2017","journal-title":"Front Pharmacol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/mt.2013.245","article-title":"TNF-\u03b1 gene silencing using polymerized siRNA\/thiolated glycol chitosan nanoparticles for rheumatoid arthritis","volume":"22","author":"Lee","year":"2014","journal-title":"Mol Ther."},{"key":"B101","doi-asserted-by":"publisher","first-page":"103434","DOI":"10.1016\/j.ebiom.2021.103434","article-title":"Low dose dexamethasone as treatment for women with heavy menstrual bleeding: a response-adaptive randomised placebo-controlled dose-finding parallel group trial (DexFEM)","volume":"69","author":"Warner","year":"2021","journal-title":"EBioMedicine."},{"key":"B102","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12958-016-0198-1","article-title":"Anti-platelet therapy holds promises in treating adenomyosis: experimental evidence","volume":"14","author":"Zhu","year":"2016","journal-title":"Reprod Biol Endocrinol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1159\/000499111","article-title":"Long-term efficacy and safety of molidustat for anemia in chronic kidney disease: DIALOGUE Extension studies","volume":"49","author":"Akizawa","year":"2019","journal-title":"Am J Nephrol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"105020","DOI":"10.1016\/j.phrs.2020.105020","article-title":"Efficacy and safety of HIF prolyl-hydroxylase inhibitor vs epoetin and darbepoetin for anemia in chronic kidney disease patients not undergoing dialysis: a network meta-analysis","volume":"159","author":"Zheng","year":"2020","journal-title":"Pharmacol Res."},{"key":"B105","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1038\/s41467-021-23448-7","article-title":"A small molecule HIF-1\u03b1 stabilizer that accelerates diabetic wound healing","volume":"12","author":"Li","year":"2021","journal-title":"Nat Commun."},{"key":"B106","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1212\/WNL.51.1.289","article-title":"Phase 1 trial of transforming growth factor beta 2 in chronic progressive MS","volume":"51","author":"Calabresi","year":"1998","journal-title":"Neurology."},{"key":"B107","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.biomaterials.2015.04.003","article-title":"Paracrine co-delivery of TGF-\u03b2 and IL-2 using CD4-targeted nanoparticles for induction and maintenance of regulatory T cells","volume":"59","author":"McHugh","year":"2015","journal-title":"Biomaterials."},{"key":"B108","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s007760300016","article-title":"Repair of full-thickness cartilage defects using liposomal transforming growth factor-beta1","volume":"8","author":"Abe","year":"2003","journal-title":"J Orthop Sci."},{"key":"B109","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1530\/JOE-20-0446","article-title":"Obesity is associated with heavy menstruation that may be due to delayed endometrial repair","volume":"249","author":"Reavey","year":"2021","journal-title":"J Endocrinol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/pin.12148","article-title":"Moesin overexpression is a unique biomarker of adenomyosis","volume":"64","author":"Ohara","year":"2014","journal-title":"Pathol Int."}],"container-title":["Frontiers in Reproductive Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frph.2021.794352\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T05:02:58Z","timestamp":1643605378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frph.2021.794352\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,31]]},"references-count":110,"alternative-id":["10.3389\/frph.2021.794352"],"URL":"https:\/\/doi.org\/10.3389\/frph.2021.794352","relation":{},"ISSN":["2673-3153"],"issn-type":[{"value":"2673-3153","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,31]]},"article-number":"794352"}}